These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37648656)

  • 1. In-perspective: the ARAMIS double-blind randomized placebo-controlled trial of anakinra for the treatment of acute myocarditis.
    Morrow DA; Verbrugge FH
    Eur Heart J Acute Cardiovasc Care; 2023 Sep; 12(9):627-628. PubMed ID: 37648656
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale and design of the ARAMIS trial: Anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis.
    Kerneis M; Cohen F; Combes A; Amoura Z; Pare C; Brugier D; Puymirat E; Abtan J; Lattuca B; Dillinger JG; Hauguel-Moreau M; Silvain J; Salem JE; Gandjbakhch E; Hekimian G; Redheuil A; Vicaut E; Montalescot G;
    Arch Cardiovasc Dis; 2023 Oct; 116(10):460-466. PubMed ID: 37640625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).
    Quartier P; Allantaz F; Cimaz R; Pillet P; Messiaen C; Bardin C; Bossuyt X; Boutten A; Bienvenu J; Duquesne A; Richer O; Chaussabel D; Mogenet A; Banchereau J; Treluyer JM; Landais P; Pascual V
    Ann Rheum Dis; 2011 May; 70(5):747-54. PubMed ID: 21173013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.
    Raffeiner B; Botsios C; Dinarello C; Ometto F; Punzi L; Ramonda R
    Joint Bone Spine; 2011 Jan; 78(1):100-1. PubMed ID: 21036649
    [No Abstract]   [Full Text] [Related]  

  • 5. Anakinra for myocarditis in juvenile idiopathic arthritis.
    Movva R; Brown SB; Morris DL; Figueredo VM
    Tex Heart Inst J; 2013; 40(5):623-5. PubMed ID: 24391342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early use of anakinra in adult-onset Still's disease myocarditis.
    Piel-Julian ML; Moulis G; Fournier P; Dupont R; Geiger D; Astudillo L; Faurie T; Pozzo J; Petermann A; Lairez O; Pugnet G; Sailler L
    Scand J Rheumatol; 2018 Nov; 47(6):511-512. PubMed ID: 29291663
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
    Abbate A; Trankle CR; Buckley LF; Lipinski MJ; Appleton D; Kadariya D; Canada JM; Carbone S; Roberts CS; Abouzaki N; Melchior R; Christopher S; Turlington J; Mueller G; Garnett J; Thomas C; Markley R; Wohlford GF; Puckett L; Medina de Chazal H; Chiabrando JG; Bressi E; Del Buono MG; Schatz A; Vo C; Dixon DL; Biondi-Zoccai GG; Kontos MC; Van Tassell BW
    J Am Heart Assoc; 2020 Mar; 9(5):e014941. PubMed ID: 32122219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.
    Cro S; Patel P; Barker J; Burden DA; Griffiths CEM; Lachmann HJ; Reynolds NJ; Warren RB; Capon F; Smith C; Cornelius V
    Trials; 2020 Feb; 21(1):158. PubMed ID: 32041649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
    Nuki G; Bresnihan B; Bear MB; McCabe D;
    Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
    Moran A; Bundy B; Becker DJ; DiMeglio LA; Gitelman SE; Goland R; Greenbaum CJ; Herold KC; Marks JB; Raskin P; Sanda S; Schatz D; Wherrett DK; Wilson DM; Krischer JP; Skyler JS; ; Pickersgill L; de Koning E; Ziegler AG; Böehm B; Badenhoop K; Schloot N; Bak JF; Pozzilli P; Mauricio D; Donath MY; Castaño L; Wägner A; Lervang HH; Perrild H; Mandrup-Poulsen T;
    Lancet; 2013 Jun; 381(9881):1905-15. PubMed ID: 23562090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis.
    Nikfar S; Saiyarsarai P; Tigabu BM; Abdollahi M
    Rheumatol Int; 2018 Aug; 38(8):1363-1383. PubMed ID: 29737371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra.
    Choi AD; Moles V; Fuisz A; Weissman G
    Int J Cardiol; 2014; 172(1):e225-7. PubMed ID: 24461482
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M
    Thromb Haemost; 2011 Nov; 106(5):959-67. PubMed ID: 21947196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
    Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
    Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
    Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G
    Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
    Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
    Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinra.
    Parisi F; Paglionico A; Varriano V; Ferraccioli G; Gremese E
    Medicine (Baltimore); 2017 Jun; 96(24):e6656. PubMed ID: 28614216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.
    Tzanetakou V; Kanni T; Giatrakou S; Katoulis A; Papadavid E; Netea MG; Dinarello CA; van der Meer JWM; Rigopoulos D; Giamarellos-Bourboulis EJ
    JAMA Dermatol; 2016 Jan; 152(1):52-59. PubMed ID: 26579854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study.
    Ilowite N; Porras O; Reiff A; Rudge S; Punaro M; Martin A; Allen R; Harville T; Sun YN; Bevirt T; Aras G; Appleton B
    Clin Rheumatol; 2009 Feb; 28(2):129-37. PubMed ID: 18766426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 study.
    Van Tassell B; Mihalick V; Thomas G; Marawan A; Talasaz AH; Lu J; Kang L; Ladd A; Damonte JI; Dixon DL; Markley R; Turlington J; Federmann E; Del Buono MG; Biondi-Zoccai G; Canada JM; Arena R; Abbate A
    J Transl Med; 2022 Jun; 20(1):270. PubMed ID: 35706006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.